David Schenkein Net Worth & Insider Trades
David Schenkein - Director, Agios Pharmaceuticals, Inc
What is David Schenkein's Net Worth?
The current estimated net worth of Agios Pharmaceuticals, Inc's Director, David Schenkein, is estimated to be about $69.24M . David Schenkein owns about 196,961 units of Agios Pharmaceuticals, Inc common stock. In the last 9 years at Agios Pharmaceuticals, Inc, David Schenkein has sold an estimated value of $57.95M worth.
What is David Schenkein's Past Insider Trading?
David Schenkein's largest purchase order was 8,064 units , worth over $249.98K on November 15, 2019. David Schenkein's largest sale order was 80,000 units , worth over $5.61M on October 5, 2017. In total, David Schenkein has made about 82 transactions over 9 years of their time at Agios Pharmaceuticals, Inc. David Schenkein usually trades in February, with the busiest year in 2017, 2015 and 2018. The most recent transaction was a sale order of 16,363 units , worth over $373.89K on April 5, 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
David Schenkein
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is David Schenkein's' Mailing Address?
- Mailing address is C/o Bluebird Bio, Inc. 840 Memorial Drive Cambridge MA 02139 MA
Agios Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Jacqualyn A. Fouse, Ph.D. | 2020 | $746,750 | - | $1,751,340 | $4,593,651 | $509,657 | $10,577 | $7,611,975 |
| Jacqualyn A. Fouse, Ph.D. | 2019 | $664,583 | - | $2,538,474 | $12,875,608 | $424,125 | $105,204 | $16,607,994 |
| Jacqualyn A. Fouse, Ph.D. | 2018 | - | - | - | - | - | - | - |
| Jonathan Biller | 2020 | $500,000 | - | - | - | $258,750 | $10,578 | $769,328 |
| Jonathan Biller | 2019 | $39,583 | $110,000 | $1,008,334 | $2,025,036 | - | $936 | $3,183,889 |
| Jonathan Biller | 2017 | - | - | - | - | - | - | - |
| Christopher Bowden, M.D. | 2020 | $515,007 | - | $618,120 | $1,508,875 | $243,341 | $9,203 | $2,894,546 |
| Christopher Bowden, M.D. | 2019 | $490,539 | - | $915,590 | $1,609,989 | $198,668 | $12,422 | $3,227,208 |
| Christopher Bowden, M.D. | 2018 | $467,141 | - | $641,025 | $1,746,517 | $262,767 | $11,280 | $3,128,730 |
| Bruce Car, Ph.D. | 2020 | $494,318 | - | $833,301 | $1,499,943 | $236,250 | $164,231 | $3,228,043 |
| Bruce Car, Ph.D. | 2019 | - | - | - | - | - | - | - |
| Bruce Car, Ph.D. | 2018 | - | - | - | - | - | - | - |
| Andrew Hirsch | 2020 | $361,234 | - | $618,120 | $1,508,875 | - | $397,893 | $2,886,122 |
| Andrew Hirsch | 2019 | $500,476 | - | $1,923,145 | $1,609,989 | $202,693 | $12,528 | $4,248,831 |
| Andrew Hirsch | 2018 | $471,329 | - | $641,025 | $1,746,517 | $265,123 | $12,864 | $3,136,858 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1439222/000119312521110205/d71514ddef14a.htm
What are Agios Pharmaceuticals, Inc's Past Insider Trades?
Agios Pharmaceuticals, Inc's most recent insider trade came on August 21, 2023 by James Burns who sold 6,395 units worth $168.06K . In the last 10 years, insiders at Agios Pharmaceuticals, Inc have sold an estimated value of $175.4M and bought an estimated value of $173.58M worth of shares. Insider trading is most common in June, with the busiest year in 2014. The most active traders at the company are David Schenkein, Director, Scott Biller, Chief Scientific Officer, and John Duncan Higgons, Chief Operating Officer .
AGIOS PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||